It depends upon the sub-population we looked at. We were looking at those on social assistance and seniors. For seniors with cognitive impairment, it increased their hospitalization rate three-fold. For those on social assistance, the biggest hit was for people with severe mental illness, where their hospitalization rate within the six months of the introduction of this policy went up six-fold. It was quite devastating, especially when drugs work. If it's a statin, you have to wait awhile for things to happen. When it comes to a drug for mental illness, or when it comes to an asthma pump, you see things happen faster. We only followed this for nine months after the policy reform, to look at what the policy-induced non-compliance did to the population. I can only comment from that perspective.
Whenever people have looked at outcomes, when it comes to cost-sharing, number one, you always see a reduction in the use of essential medication when you do it. Number two, if you believe those medicines work—take the subset that do work—and you look in the short term for things where it works like your insulin pump, you're going to see complications happen quickly.